PLAUR and triple-negative breast carcinoma: This antibody, identified from a human phage display library, binds human (KD ~10–40 nM) but not mouse uPAR, prevented the uPA-uPAR interaction, and showed in vivo diagnostic and therapeutic efficacy in triple-negative breast cancer (TNBC) tumor xenografts and a metastatic mouse model [166,167].